Delivery Order SPE2DB22D1202-SPE2DB24FVAY9
Award Date
5/20/24
Potential Completion Date
5/21/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a ceiling value of $6,380.88 and an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,192.00, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $9,479.97 and is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 12, 2024. The contract is not designated with a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,877.84 firm fixed-price delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $9,926.94 with a completion date of December 20, 2024. It is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This federal contract award, valued at $1,961.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of November 18, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,653.57, is for the procurement of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract has an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a prescription medication. The $13,785.98 firm-fixed-price contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a wide...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The award is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...